Dehydrocorydaline

(Synonyms: 13-Methylpalmatine)
47 Cited Publications
Customer Review

Based on 47 publication(s) in Google Scholar

Dehydrocorydaline (13-Methylpalmatine) is an orally active alkaloid that inhibits acetylcholinesterase (AChE) (IC50 = 0.62 μM). Dehydrocorydaline inhibits synaptosomal reuptake of serotonin/dopamine/norepinephrine, the NLRP3 inflammasome, microglial activation, biofilm formation, and Plasmodium/Trypanosoma growth, and has pain-relieving effects. Dehydrocorydaline activates p38 MAPK/MyoD-driven myoblast differentiation, binds SPTA1 (Kd = 2.18 µM), inhibits aldose reductase, hOCT2/3, hPMAT, MEK/ERK, NF-κB/TRAF6, IRE1/PERK, SMAD2/3, and NR2B phosphorylation, and modulates Bcl-2/Bax, caspase-8/7, and PARP signaling. Dehydrocorydaline can be used in research on pain, breast cancer, melanoma, non-small cell lung cancer, bacterial infections, parasitic infections, pulmonary fibrosis, and atherosclerosis.

For research use only. We do not sell to patients.

  • Purity : 99.16%
  • CAS No.: 30045-16-0
  • Formula: C22H24NO4+
  • Molecular Weight:366.43
  • Storage:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Protocols
  • Purity & Documentation
  • References
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00